FDA approves mepolizumab (Nucala; GSK) as the first monthly biologic for chronic obstructive pulmonary disease (COPD), significantly reducing exacerbations in patients with an eosinophilic phenotype.

Learn what causes esophageal strictures, how they're diagnosed, and the latest treatments to ease swallowing and improve ...

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...

This World EoE Day – the first ever – we’re encouraging people around the globe to spread awareness of EoE and talk to a doctor if they recognize symptoms of EoE in themselves or a loved one.” — Mary ...

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology ...

The dynamics of the eosinophilic esophagitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as APT-1011 (Ellodi Pharmaceuticals) ...

AQILION AB (publ) today announces that the US Food and Drug Administration (FDA) has approved Aqilion's IND (investigational new drug) application for the drug candidate AQ280. The first study in the ...

Primary symptoms include vision problems (like blurred or double vision), tingling and numbness in face/arms/legs/fingers, chronic pain and involuntary muscle spasms, unexplained fatigue and ...

With severe hypercapnia, though, the symptoms and complications can become life-threatening. Hypercapnia affects your blood's pH balance. When you have hypercapnia, your blood becomes too acidic. If ...

People with coeliac disease have shared the most common symptoms they experienced which led to them getting a diagnosis. Coeliac disease is an autoimmune condition caused by a negative response to ...

There are several types of esophagitis, such as reflux, eosinophilic (EoE), and infectious, each with different causes and characteristics. Common symptoms of esophagitis include difficulty ...